论文部分内容阅读
目的:研究讨论头孢呋辛钠联合痰热清治疗老年肺气肿治疗效果。方法:选择该医院于2012年3月至今收治老年肺气肿患者85例,将其随机分为研究组与对照组,研究组采用头孢呋辛钠联合痰热清对患者进行药物治疗,对照组单独采用痰热清进行药物治疗,用药一段时间后对患者呼吸困难症状进行观察记录,记录患者体温、症状缓解时间、胸部X线下体征及不良反应发生情况。结果:两组患者用药后呼吸困难状况皆得以减弱,3h内呼吸困难患者比例差异未见统计意义(P>0.05),4~7小时后研究组呼吸困难患者数量较对照组少,差异有统计意义(P<0.05),7 h后研究组呼吸困难患者比例皆少于对照组,差异有统计意义(P<0.05)。结论:头孢呋辛钠联合痰热清治疗老年肺气肿,治疗效果明显优于单独使用痰热清,患者不良反应较少,治疗方法安全可靠,可于临床广泛推行。
Objective: To study and discuss the therapeutic effect of cefuroxime sodium combined with Tanreqing on elderly patients with emphysema. Methods: Eighty-five elderly patients with emphysema were admitted to our hospital from March 2012 to present. The patients were randomly divided into study group and control group. The study group was treated with cefuroxime sodium combined with Tanreqing and the control group Tanreqing alone for drug treatment, medication for some time after the symptoms of dyspnea patients were observed and recorded, record the patient’s temperature, symptom relief time, chest X-ray signs and adverse reactions. Results: The dyspnoea in both groups were weakened after treatment, and there was no significant difference in the proportion of dyspnea patients within 3 hours (P> 0.05). After 4 to 7 hours, the number of dyspnea patients in the study group was less than that in the control group (P <0.05). After 7 hours, the proportion of dyspnea patients in the study group was less than that in the control group (P <0.05). Conclusion: Cefuroxime sodium combined with Tanreqing treatment of elderly patients with emphysema, the treatment effect was significantly better than the Tanreqing alone, patients with fewer adverse reactions, the treatment is safe and reliable, widely available in clinical practice.